Literature DB >> 21402601

Does extended telephone callback counselling prevent smoking relapse?

C J Segan1, R Borland.   

Abstract

This randomized controlled trial tested whether extended callback counselling that proactively engaged ex-smokers with the task of embracing a smoke-free lifestyle (four to six calls delivered 1-3 months after quitting, i.e. when craving levels and perceived need for help had declined) could reduce relapse compared with a revised version of Quitline's standard service (four calls in the first month after quitting which focused primarily on the task of helping ex-smokers deal with daily cravings and now also systematically alerted clients to the upcoming task of adapting to life as a non-smoker). One thousand and four hundred and forty-four smokers or recent ex-smokers were randomized at recruitment: 734 usual care and 710 intervention. An inclusion criterion of subsequently quitting for at least 1 week gave 346 usual care and 352 intervention participants. Seventy-four per cent of intervention participants accepted extra calls and received 4.3 on average but only 1.7 more post-quitting calls than usual care group. No significant differences were found between extended contact and usual care groups on continuous abstinence (both 27% at 12 months) or any other cessation outcome. The tasks of quitting framework introduced in preparation for the trial might have contributed to service improvement in relapse prevention (10% increased quit rate compared with an earlier trial). However, the extra sessions did not provide any benefit.

Entities:  

Mesh:

Year:  2011        PMID: 21402601     DOI: 10.1093/her/cyr009

Source DB:  PubMed          Journal:  Health Educ Res        ISSN: 0268-1153


  9 in total

Review 1.  A systematic review of the relationships between craving and smoking cessation.

Authors:  Jennifer M Wray; Julie C Gass; Stephen T Tiffany
Journal:  Nicotine Tob Res       Date:  2013-01-04       Impact factor: 4.244

2.  Relapse prevention interventions for smoking cessation.

Authors:  Jonathan Livingstone-Banks; Emma Norris; Jamie Hartmann-Boyce; Robert West; Martin Jarvis; Emma Chubb; Peter Hajek
Journal:  Cochrane Database Syst Rev       Date:  2019-10-28

3.  Relapse prevention interventions for smoking cessation.

Authors:  Jonathan Livingstone-Banks; Emma Norris; Jamie Hartmann-Boyce; Robert West; Martin Jarvis; Peter Hajek
Journal:  Cochrane Database Syst Rev       Date:  2019-02-13

4.  How much unsuccessful quitting activity is going on among adult smokers? Data from the International Tobacco Control Four Country cohort survey.

Authors:  Ron Borland; Timea R Partos; Hua-Hie Yong; K Michael Cummings; Andrew Hyland
Journal:  Addiction       Date:  2012-03       Impact factor: 6.526

5.  Do post-quitting experiences predict smoking relapse among former smokers in Australia and the United Kingdom? Findings from the International Tobacco Control Surveys.

Authors:  Bradley Gorniak; Hua-Hie Yong; Ron Borland; K Michael Cummings; James F Thrasher; Ann McNeill; Andrew Hyland; Geoffrey T Fong
Journal:  Drug Alcohol Rev       Date:  2021-12-09

6.  Telephone counselling for smoking cessation.

Authors:  William Matkin; José M Ordóñez-Mena; Jamie Hartmann-Boyce
Journal:  Cochrane Database Syst Rev       Date:  2019-05-02

7.  Effects of timing of initiation and planning on smoking cessation outcomes: study protocol for a randomised controlled trial.

Authors:  Ron Borland; James Balmford; Elena Swift
Journal:  BMC Public Health       Date:  2013-03-18       Impact factor: 3.295

8.  Effectiveness of proactive and reactive services at the Swedish National Tobacco Quitline in a randomized trial.

Authors:  Eva Nohlert; John Ohrvik; Asgeir R Helgason
Journal:  Tob Induc Dis       Date:  2014-06-03       Impact factor: 2.600

9.  Additional follow-up telephone counselling and initial smoking relapse: a longitudinal, controlled study.

Authors:  Lei Wu; Yao He; Bin Jiang; Fang Zuo; Qinghui Liu; Li Zhang; Changxi Zhou
Journal:  BMJ Open       Date:  2016-04-20       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.